skip to content
Monoamine oxidase inhibitors in neurological diseases Preview this item
ClosePreview this item
Checking...

Monoamine oxidase inhibitors in neurological diseases

Author: A N Lieberman
Publisher: New York : M. Dekker, ©1994.
Series: Neurological disease and therapy, v. 21.
Edition/Format:   Print book : EnglishView all editions and formats
Summary:
"Emphasizing the role of monoamine oxidase (MAO) in the etiology and pathogenesis of Parkinson's disease and Alzheimer's disease, this up-to-date reference describes the genetics, physiology, biochemistry, pharmacology, and clinical aspects of this very important class of enzymes. Details how the interaction between selegiline (deprenyl) and MAO may retard the progression of neurodegenerative disorders! Providing  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Document Type: Book
All Authors / Contributors: A N Lieberman
ISBN: 0824790820 9780824790820
OCLC Number: 28587707
Description: xviii, 371 pages : illustrations ; 24 cm.
Contents: The Distribution of Monoamine Oxidases A and B in Normal Human Brain, Karin N. Westlund Effects of Disease and Aging on Monoamine Oxidases A and B, Manfred Gerlach, Peter Riederer, and Moussa B. H. Youdim Biochemistry and Mechanism of Action of Monoamine Oxidases A and B, Eimear M. O'Brien and Keith F. Tipton The Structure, Gene, and Promoter Organization of Monoamine Oxidases A and B, Jean Chen Shih, Kevin Chen, Joseph S. Grimsby, Qin-Shi Zhu, and Timothy K. Gallaher Molecular Genetics and Inheritance of Human Monoamine Oxidases A and B, Xandra O. Breakefield, Zheng-Yi Chen, Elizabeth Tivol, Christo Shalish, and Ian W. Craig Role of Monoamine Oxidase Genetics in the Etiology of Parkinson's Disease, Janice H. Kurth and Matthias C. Kurth Multiple Forms of Monoamine Oxidase and Iron: Their Relevance to the Pathology and Treatment of Parkinson's Disease, Moussa B. H. Youdim, Dorit Ben-Shachar, and Peter Riederer A Critical Role for Monoamine Oxidase in Toxin Action in Parkinson's Disease, Peter Jenner Effects of Monoamine Oxidase B Inhibitors on Dopaminergic Function: Role of 2-Phenylethylamine and Aromatic L-Amino Acid Decarboxylase, Augusto V. Juorio, Xin-Min Li, I. A. Paterson, and Alan A. Boulton Inhibition of Monoamine Oxidase B and the Neuroprotective Effects of Selegiline, Kevin T. Finnegan Reduction of Nerve Cell Death by Deprenyl Without Monoamine Oxidase Inhibition, William G. Tatton, Nadine A. Seniuk, William Y. H. Ju, and Karen S. Ansari Monoamine Oxidase Inhibitors as Neuroprotective Therapy, Warren Olanow and Donald B. Calne Selegiline as Symptomatic Treatment for Parkinson's Disease, Abraham Lieberman Monoamine Oxidase Inhibitors in Alzheimer's Disease, Jody Corey-Bloom and Leon J. Thal Role of Monoamine Oxidase Inhibitors in Psychiatry, David J. Houlihan and Samuel Gershon
Series Title: Neurological disease and therapy, v. 21.
Responsibility: edited by Abraham Lieberman [and others].
More information:

Abstract:

Emphasizing the role of monoamine oxidase (MAO) in the etiology and pathogenesis of Parkinson's disease and Alzheimer's disease, this title describes the genetics, physiology, biochemistry,  Read more...

Reviews

Editorial reviews

Publisher Synopsis

"This book represents a good review of this subject. "-Neurological Research

 
User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/28587707> # Monoamine oxidase inhibitors in neurological diseases
    a schema:CreativeWork, schema:Book ;
   library:oclcnum "28587707" ;
   library:placeOfPublication <http://dbpedia.org/resource/New_York_City> ; # New York
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/nyu> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/enzyminhibitoren> ; # Enzyminhibitoren
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/monoamine_oxidase_metabolism> ; # Monoamine Oxidase--metabolism
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/zenuwstelselaandoeningen> ; # Zenuwstelselaandoeningen
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/parkinson_disease_drug_therapy> ; # Parkinson Disease--drug therapy
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/parkinson_disease_etiology> ; # Parkinson Disease--etiology
   schema:about <http://id.loc.gov/authorities/subjects/sh85098116> ; # Parkinson's disease--Chemotherapy
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/selegiline_therapeutic_use> ; # Selegiline--Therapeutic use
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/mao_hemmer> ; # MAO-Hemmer
   schema:about <http://id.loc.gov/authorities/subjects/sh85086886> ; # Monoamine oxidase
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/monoamine_oxidase_inhibitors_therapeutic_use> ; # Monoamine Oxidase Inhibitors--therapeutic use
   schema:about <http://id.worldcat.org/fast/1025523> ; # Monoamine oxidase
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/nervensystem> ; # Nervensystem
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/nervous_system_degeneration_chemotherapy> ; # Nervous system--Degeneration--Chemotherapy
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/selegiline> ; # Selegiline
   schema:about <http://id.worldcat.org/fast/1025525> ; # Monoamine oxidase--Inhibitors--Therapeutic use
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/monoamineoxidase> ; # Monoamineoxidase
   schema:about <http://experiment.worldcat.org/entity/work/data/24746205#Topic/krankheit> ; # Krankheit
   schema:about <http://dewey.info/class/616.8/e20/> ;
   schema:about <http://id.worldcat.org/fast/1053695> ; # Parkinson's disease--Chemotherapy
   schema:bookFormat bgn:PrintBook ;
   schema:contributor <http://viaf.org/viaf/61623588> ; # Abraham N. Lieberman
   schema:copyrightYear "1994" ;
   schema:datePublished "1994" ;
   schema:description ""Emphasizing the role of monoamine oxidase (MAO) in the etiology and pathogenesis of Parkinson's disease and Alzheimer's disease, this up-to-date reference describes the genetics, physiology, biochemistry, pharmacology, and clinical aspects of this very important class of enzymes. Details how the interaction between selegiline (deprenyl) and MAO may retard the progression of neurodegenerative disorders! Providing the latest theories on how selegiline operates, Monoamine Oxidase Inhibitors in Neurological Diseases - presents fundamental information on MAO types A and B - examines the distribution of MAO A and B in the normal human brain - investigates the effects of disease and aging on MAO A and B - analyzes a critical role for MAO in the toxic action in Parkinson's disease - elucidates selegiline's novel ability to delay the progression or repair the damage of dopaminergic neurons - discusses the usefulness of MAO inhibitors in psychiatric disease - and more!!"--Publisher description (LoC)."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/24746205> ;
   schema:inLanguage "en" ;
   schema:isPartOf <http://experiment.worldcat.org/entity/work/data/24746205#Series/neurological_disease_and_therapy> ; # Neurological disease and therapy ;
   schema:name "Monoamine oxidase inhibitors in neurological diseases"@en ;
   schema:productID "28587707" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/28587707#PublicationEvent/new_york_m_dekker_1994> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/24746205#Agent/m_dekker> ; # M. Dekker
   schema:workExample <http://worldcat.org/isbn/9780824790820> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/28587707> ;
    .


Related Entities

<http://dbpedia.org/resource/New_York_City> # New York
    a schema:Place ;
   schema:name "New York" ;
    .

<http://experiment.worldcat.org/entity/work/data/24746205#Series/neurological_disease_and_therapy> # Neurological disease and therapy ;
    a bgn:PublicationSeries ;
   schema:hasPart <http://www.worldcat.org/oclc/28587707> ; # Monoamine oxidase inhibitors in neurological diseases
   schema:name "Neurological disease and therapy ;" ;
    .

<http://experiment.worldcat.org/entity/work/data/24746205#Topic/monoamine_oxidase_inhibitors_therapeutic_use> # Monoamine Oxidase Inhibitors--therapeutic use
    a schema:Intangible ;
   schema:hasPart <http://id.loc.gov/authorities/subjects/sh85086887> ;
   schema:name "Monoamine Oxidase Inhibitors--therapeutic use"@en ;
   schema:name "Monoamine oxidase--Inhibitors--Therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/24746205#Topic/monoamine_oxidase_metabolism> # Monoamine Oxidase--metabolism
    a schema:Intangible ;
   schema:name "Monoamine Oxidase--metabolism"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/24746205#Topic/nervous_system_degeneration_chemotherapy> # Nervous system--Degeneration--Chemotherapy
    a schema:Intangible ;
   schema:hasPart <http://id.loc.gov/authorities/subjects/sh85090923> ;
   schema:name "Nervous system--Degeneration--Chemotherapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/24746205#Topic/parkinson_disease_drug_therapy> # Parkinson Disease--drug therapy
    a schema:Intangible ;
   schema:name "Parkinson Disease--drug therapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/24746205#Topic/parkinson_disease_etiology> # Parkinson Disease--etiology
    a schema:Intangible ;
   schema:name "Parkinson Disease--etiology"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/24746205#Topic/zenuwstelselaandoeningen> # Zenuwstelselaandoeningen
    a schema:Intangible ;
   schema:name "Zenuwstelselaandoeningen"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh85086886> # Monoamine oxidase
    a schema:Intangible ;
   schema:name "Monoamine oxidase"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh85098116> # Parkinson's disease--Chemotherapy
    a schema:Intangible ;
   schema:name "Parkinson's disease--Chemotherapy"@en ;
    .

<http://id.worldcat.org/fast/1025523> # Monoamine oxidase
    a schema:Intangible ;
   schema:name "Monoamine oxidase"@en ;
    .

<http://id.worldcat.org/fast/1025525> # Monoamine oxidase--Inhibitors--Therapeutic use
    a schema:Intangible ;
   schema:name "Monoamine oxidase--Inhibitors--Therapeutic use"@en ;
    .

<http://id.worldcat.org/fast/1053695> # Parkinson's disease--Chemotherapy
    a schema:Intangible ;
   schema:hasPart <http://id.loc.gov/authorities/subjects/sh85098116> ; # Parkinson's disease--Chemotherapy
   schema:name "Parkinson's disease--Chemotherapy"@en ;
    .

<http://viaf.org/viaf/61623588> # Abraham N. Lieberman
    a schema:Person ;
   schema:birthDate "1938" ;
   schema:familyName "Lieberman" ;
   schema:givenName "Abraham N." ;
   schema:givenName "A. N." ;
   schema:name "Abraham N. Lieberman" ;
    .

<http://worldcat.org/isbn/9780824790820>
    a schema:ProductModel ;
   schema:isbn "0824790820" ;
   schema:isbn "9780824790820" ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.